Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
5/17/2021
State Council Approves Cross-border Retail e-Commerce Trial for Import...
5/17/2021
China Indicates Support of IP Waiver for Coronavirus Vaccines
5/17/2021
Everest Med's BLA for Sacituzumab Govitecan-Hziy Accepted in China
5/17/2021
Iconovo Extends Deal with Amneal for Generic Symbicort to Cover Key Ma...
5/17/2021
Lilly/Innovent File U.S. BLA for Sintilimab in Combo with Pemetrexed a...
5/14/2021
Reuters: Kintor's COVID-19 Drug Claims Trigger Skepticism
5/14/2021
Pregene and Dr. Reddy's Announce License Agreement for Anti-BCMA CAR-T...
5/14/2021
Antengene Announces the IND Approval for Eltanexor in Patients with Ad...
5/14/2021
CDE Solicits Comments on the Guidelines for Clinical Trial of Therapeu...
5/14/2021
CDE Solicits Comments on the Guidelines for Writing Relevant Pediatric...
5/14/2021
PharmaDJ's China Market Approval Tracker: March 2021
5/13/2021
Antengene Granted Chinese IND Approval for a Global PIII Trial of Sel...
5/13/2021
China Inaugurates State Administration of Disease Prevention and Contr...
5/13/2021
NMPA Issues the Guidelines for Pharmacovigilance Quality Control
5/13/2021
NHC Issues the 2021 Edition of Diagnostic and Therapeutic Guidelines f...
5/12/2021
GlobalData: New Chinese Breakthrough Therapy Designation Attracts Fore...
5/12/2021
CDE Solicits Comments on the Guidelines for Clinical Trial Protocol De...
5/12/2021
IQVIA: Chinese Hospital Drug Market Down 10.7% in 2020
5/12/2021
Citrine and Diurnal Enter Partnership to Pring Efmody to China for...
5/12/2021
Pharma e-Commerce Operator Beijing Yuanxin Eyes HK IPO
5/11/2021
Sumitomo Dainippon and Sinovant Enter License Pact for Select Asian Pr...
5/11/2021
Shanghai-based Alebund Pharma Raises $60M in Series B Financing Round
5/11/2021
AmCham White Paper Calls on China to Play Fair
5/11/2021
Nanobiotix and LianBio Tie Up for First-in-Class Radioenhancer NBTXR3 ...
5/11/2021
China's Population Growth Closer to Zero
5/11/2021
IQVIA's New Report: Global Medicine Spending and Usage Trends: Outlook...
5/11/2021
Nature: Characteristics of Expedited Programmes for Cancer Drug Approv...
5/10/2021
Fosun and BioNTech to Form JV for Chinese Production of mRNA Vaccines
5/10/2021
State Council Issues New Policy Document on Boosting Drug Regulatory C...
5/10/2021
NHSA and NHC Issues Policy Document for "Twin-Channel" Mechanism of Ne...
Page:
131
/
719
Total number of articles:
21549
:
[First]
[<<]
[129]
[130]
[131]
[132]
[133]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit